부산대학교 도서관

Bohula, Erin A, MD; Scirica, Benjamin M, MD; Inzucchi, Silvio E, Prof; McGuire, Darren K, Prof; Keech, Anthony C, Prof; Smith, Steven R, MD; Kanevsky, Estella, MS; Murphy, Sabina A, MPH; Leiter, Lawrence A, Prof; Dwyer, Jamie P, Prof; Corbalan, Ramon, MD; Hamm, Christian, Prof; Kaplan, Lee, MD; Nicolau, Jose Carlos, Prof; Ophuis, Ton Oude, MD; Ray, Kausik K, Prof; Ruda, Mikhail, Prof; Spinar, Jindrich, MD; Patel, Tushar, PhD; Miao, Wenfeng, MD; Perdomo, Carlos, MS; Francis, Bruce, MD; Dhadda, Shobha, PhD; Bonaca, Marc P, MD; Ruff, Christian T, MD; Sabatine, Marc S, Prof; Wiviott, Stephen D, MD; Inzucchi, Silvio; Keech, Anthony; Satlin, Andrew; Brown, Conville; Budaj, Andrzej; Dwyer, Jamie; Garcia-Castillo, Armando; Gupta, Milan; Oude Ophuis, Ton; Ray, Kauski; Weissman, Neil; White, Harvey D; Amerena, J; Arstall, M; Colquhoun, D; Jayasinghe, R; Lee, A; Lehman, R; Moses, R; Proietto, J; Purnell, P; Waites, J; Blombery, P; Cross, D; Worthley, M; d'Emden, M; Selvanayagam, J; Oqueli, RE; Whelan, A; Garrahy, P; de Looze, F; Ninio, D; Horowitz, J; William, M; Suranyi, M; Wittert, G; Le May, M; Pandey, AS; Vizel, S; Labonte, R; Beaudry, Y; Fortin, C; Bell, A; Kouz, S; St-Amour, É; Bata, I; St Maurice, F; Chehayeb, R; Constance, C; Wong, G; Hess, A; Liutkus, J; Poirier, P; Teitelbaum, I; Berlingieri, J; Cha, J; Hartleib, M; Heffernan, M; Twum-Barima, D; Pandith, V; Aronson, R; Goldenberg, R; Ajala, B; Jain, A; Ross, S; Bajaj, H; Khandwala, H; Yared, Z; Gupta, N; Bédard, J; Wharton, S; Blouin, F; Savard, D; Shukla, D; Cobos, J; Godoy, G; Perez, L; Pincetti, C; Saavedra Guajardo, V; Varleta, P; Conejeros, C; Lanas, F; Bayram Llamas, E; Cardona Muñoz, E; Garcia, R; Garza Ruiz, J; Llamas Esperon, G; Lopez Rosas, E; Melendez Mier, G; Ramos, G; Hart, H; Scott, D; Ternouth, I; Benatar, J; Elliott, J; Cutfield, R; Manning, P; Williams, M; Ferrier, K; Scott, R; Wilson, S; Leikis, R; Nirmalaraj, BK; Krzyżagórska, E; Miękus, P; Bronisz, M; Mirek-Bryniarska, E; Łanda, K; Stasiewski, A; Żechowicz, T; Zytkiewicz-Jaruga, D; Korecki, J; Ogórek, M; Pawłowicz, L; Piepiorka, M; Skierkowska, J; Stankiewicz, A; Szyprowska, E; Witek, R; Bochenek, A; Kończakowski, P; Wojnowski, Ł; Wujkowski, M; Cymerman, K; Korzeniak, R; Mąder, P; Mikłaszewicz, B; Stachlewski, P; Goch, A; Pomiećko, W; Skórski, M; Romanowski, L; Jusiak, K; Laskowska-Derlaga, E; Bijata-Bronisz, R; Kaźmierczak, J; Goldberg, R; Henderson, D; Korban, E; Rohr, K; Claxton, E; Weiss, R; Angiolillo, D; Boccalandro, F; Chu, K; Thorn, E; Randhawa, P; Singh, N; Bittar, G; Guarnieri, T; Saeed, S; Sharma, S; Shepard, M; French, W; Desai, P; Bernstein, R; Rogers, W; Singal, R; Schneider, R; Shanes, J; Ong, S; Condit, J; Donahoe, S; Brill, D; Einhorn, D; Ebrahimi, R; Labroo, A; Graf, R; Scott, J; Hoekstra, J; Jetty, P; Luckasen, G; O'Donnell, P; Gonte, W; Pomposini, D; Quadrel, M; Koren, M; Schlager, D; Schramm, E; Singal, D; Lupovitch, S; Soni, A; Seigel, P; Roberts, J; Soufer, J; Reza, S; Quinlan, E; Moretto, T; First, B; Khan, M; Chilka, S; Colfer, H; Teklinski, A; Wallace-Wilding, K; Ellison, H; Muse, D; Aronoff, S; Higgins, A; Patel, S; Elinoff, V; Karim, A; Awasty, V; Chuang, R; Roseman, H; Dugano-Daphnis, P; Albert, M; Sheikh, K; Bays, H; Kaster, S; Goldstein, M; Rubino, D; Calatayud, G; Snyder, H; Williams, T; Hershon, K; Hagan, M; Isserman, S; Kahn, B; Anderson, J; Gimness, MP; Raisinghani, A; Christina, M; Raikhel, M; Gillespie, E; Portnay, E; Heiman, M; Qureshi, M; Lee, J; Blonder, R; Cucher, F; Miller, G; Kotlaba, D; Cornett, G; Beavins, J; Augenbraun, C; Reinhardt, S; Bartkowiak, A, Jr; Salacata, A; Blevins, T; Benjamin, S; Diener, J; George, W; Barker, B; Richwine, R; Baldari, D; Alfieri, A; Barreto, A; Zhang, L; Shah, R; Hendrix, E; Subramaniyam, V; Hurley, S; Lillestol, M; O'Donoghue, M; Shayani, S; Ryan, E; Call, R; Zemel, L; Chang, A; Kivitz, A; Freyne, B; Bland, V; Shore, K; Mostel, E; Uzoaga, E; Andrawis, N; Gabra, N; Ghitis, A; Sabatino, K; Browder, D; Varma, S; Smith, S; Fink, R; Aycock, GR, Jr; Doty, WD; Alfonso, T; Eshaghian, S; Karlsberg, R; Zarich, S; Landau, C; McKenzie, M; Krause, R; Davis, W; Haddad, T; Voyce, S; Alford, C; LeDoux, J; O'Dea, D; Park, J; Aroda, V; Getaneh, A; Graham, B; Bhagwat, R; Korn, D; Ruoff, G; Wiseman, A; Lieber, I; Fialkow, J; Gonzalez-Campoy, JM; Bayron, C; Bertolet, B; Lash, J; Gerrish, C; Robertson, D; Rosenfeld, J; Seidner, M; Agaiby, J; Silverfield, J; Sugimoto, D; Lubin, B; Alhaddad, M; Lui, H; Lakin, G; Chokshi, S; Donovan, D; Felten, W; Minton, S; Kimmelstiel, C; Kuvin, J; Still, C; Byars, W; Talano, J; Desai, V; Bradley, AJ, III; Baker, S; Chane, M; Mercado, A; Baron, S; Harris, B; Mayer, N; Concha, M; Carr, K; Chaykin, L; Willis, J; Clay, A; Fenstad, E; Furda, J; Peterson, P; Chang, M; Aronne, L; Jones, D; Prashad, R; Benson, M; Stegemoller, R; Longshaw, K; Saleh, J; Jennings, W; Detweiler, R; Viswanath, D; Patel, R; Lederman, S; Weinstein, D; Korabathina, R; Singh, V; Rosen, J; Estevez, R; Levin, P; McNeill, R; Kalen, V; Reed, J; Ashley, R; Herman, L; Tsai, Y; Kayne, D; White, A; Hussain, I; Tami, L; Cohen, K; Robinson, J; Fuchs-Ertman, D; Platt, G; Belardo, L; Reddy, R; Rosendorff, C; Saba, F; Powell, S; Anderson, K; Abidi, M; Rezkalla, S; Paraschos, A; Wilson, J; Moursi, M; Shah, A; Nadar, V; Stonesifer, L; Bialow, M; Cannon, K; Ellison, W; Stedman, M; Brown, J; Harper, W; Lucas, KJ; DiGiovanna, M; Rodbard, H; Biscoveanu, M; Davis, C; Hall, J; Littlefield, R; Gorman, T; Kereiakes, D; Chang, FM; Tatu, H; Cheung, D; Kaine, J; Knutson, T; Logemann, T; Pueblitz, G; Bianco, J; Henson, B; Neustel, M; Gelernt, M; Nelson, W; Moriarty, K; Lefebvre, G; Maw, K; Rink, L; Behn, P; Studdard, H; Argoud, G; O'Connor, T; Krichmar, P; Raad, G; Pereles-Ortiz, J; Sorli, C; Cohen, A; Pettis, K; Cavanaugh, B; Phillips, C; Wahlen, J; Radin, D; Rider, J; Kosinski, E; Leimbach, W; Odhav, A; Hakas, J; Tan, A; Howell, M; Wombolt, D; Fishman, N; Shah, P; Wylie, P; Arauz-Pacheco, C; Cavale, A; George, A; Kroll, R; Krantzler, J; Tahirkheli, N; Jabro, M; Newell, M; Mullen, P; Gencheff, N; Meli, J; Vora, K; Kotek, L; Pyzdrowski, K; Paez, H; Moran, J; Tannenbaum, A; Deck, K; Busch, R; Levinson, L; Azizad, M; Whitaker, J; Fox, B; Huffman, C; Ashraf, M; Diogo, J; Kushner, R; Tallet, J; Channamsetty, V; Suh, D; Atieh, M; Navas, J; Young, V; Shaw, S; Dor, I; Duffy, B; Rubin, P; Lewis, D; Kaye, W; Benton, R; Burbano, J; Hotchkiss, D; Magno, A; Alberton, A; Collins, J; Alvarado, O; Stich, M; Mahal, S; Liu, J; Hong, M; Dy, J; Block, B; Lamantia, J; Pritchard, J; Davis, M; Srivastava, S; Bilazarian, S; Rosario, R; McCartney, M; Blumberg, V; Rajan, R; Martin, E; Wright, S; Brinson, C; Johnston, J; Graves, M; Dominguez, M; McKenzie, W; Abadier, R; Tran, C; Castello, R; Morawski, E; White, J; Morris, F; Perez, A; Trueba, P; Sanchez, M; Andersen, J; Kastelic, R; Khan, J; Rodriguez, H; Izquierdo, W; Matias, A; Essandoh, L; Ince, C

The Lancet. 392(10161):2269-2279

Hudson Scholle S; Nguyen-Louie TT; Bifulco L; Blaz JW; Blankson ML; Channamsetty V; Anderson DR

Journal of Pain Research, Vol 15, Pp 2249-2261 (2022)

Channamsetty Praveena; Ramesh S. Chaughule; K. V. Satyanarayana

Advances in Dental Implantology using Nanomaterials and Allied Technology Applications ISBN: 9783030522063

Emery Tavernier RL; Weitzman Institute, Moses Weitzman Health System, Washington, District of Columbia.; University of Minnesota Medical School, Duluth Campus, Duluth, Minnesota.; Rogers P; Weitzman Institute, Moses Weitzman Health System, Washington, District of Columbia.; Shenkman M; Wesleyan University, Middletown, Connecticut.; Moore A; Weitzman Institute, Moses Weitzman Health System, Washington, District of Columbia.; Sailor B; Community Health Center, Inc, Middletown, Connecticut.; Channamsetty V; Community Health Center, Inc, Middletown, Connecticut.; Highsmith Y; Community Health Center, Inc, Middletown, Connecticut.; Flinter M; Weitzman Institute, Moses Weitzman Health System, Washington, District of Columbia.; Community Health Center, Inc, Middletown, Connecticut.

Publisher: Wiley Country of Publication: United States NLM ID: 100909407 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-2011 (Electronic) Linking ISSN: 15269523 NLM ISO Abbreviation: J Midwifery Womens Health Subsets: MEDLINE

Ramirez, A.H.; Wilkins, C.; Roden, D.M.; Schully, S.D.; Hentges, J.; Mockrin, S.; Lunt, C.; Devaney, S.A.; Gebo, K.; Denny, J.C.; Sulieman, L.; Halvorson, A.; Qian, J.; Carroll, R.J.; Harris, P.A.; Schlueter, D.J.; Ratsimbazafy, F.; Loperena, R.; Mayo, K.; Basford, M.; Deflaux, N.; Muthuraman, K.N.; Glazer, D.; Natarajan, K.; Hripcsak, G.; Kho, A.; Xu, H.; Anton-Culver, H.; Boerwinkle, E.; Cicek, M.; Clark, C.R.; Karlson, E.W.; Cohn, E.; Ohno-Machado, L.; Ahmedani, B.K.; Argos, M.; Cronin, R.M.; O'Donnell, C.; Fouad, M.; Goldstein, D.B.; Greenland, P.; Hebbring, S.J.; Khatri, P.; Korf, B.; Smoller, J.W.; Sodeke, S.; Wilbanks, J.; Philippakis, A.; Ahmedani, B.; Cole Johnson, C.D.; Ahsan, H.; Antoine-LaVigne, D.; Singleton, G.; Topol, E.; Baca-Motes, K.; Steinhubl, S.; Wade, J.; Begale, M.; Jain, P.; Sutherland, S.; Lewis, B.; Behringer, M.; Gharavi, A.G.; Bier, L.; Brilliant, M.H.; Murali, N.; Hebbring, S.J.; Farrar-Edwards, D.; Burnside, E.; Drezner, M.K.; Taylor, A.; Channamsetty, V.; Montalvo, W.; Sharma, Y.; Chinea, C.; Jenks, N.; Thibodeau, S.; Holmes, B.W.; Schlueter, E.; Collier, E.; Winkler, J.; Corcoran, J.; D'Addezio, N.; Daviglus, M.; Winn, R.; Roden, D.; Denny, J.; Doheny, K.; Nickerson, D.; Eichler, E.; Jarvik, G.; Funk, G.; Rehm, H.; Lennon, N.; Kathiresan, S.; Gabriel, S.; Gibbs, R.; Gil Rico, E.M.; Grand, J.; Harris, P.; Shenkman, E.; Hogan, W.R.; Igho-Pemu, P.; Pollan, C.; Jorge, M.; Okun, S.; Smoller, J.; Murphy, S.N.; Ross, M.E.; Kaushal, R.; Winford, E.; Wallace, F.; Kheterpal, V.; Ojo, A.; Moreno, F.A.; Kron, I.; Peterson, R.; Menon, U.; Lattimore, P.W.; Leviner, N.; Obedin-Maliver, J.; Lunn, M.; Malik-Gagnon, L.; Mangravite, L.; Marallo, A.; Marroquin, O.; Visweswaran, S.; Reis, S.; Marshall, G.; McGovern, P.; Mignucci, D.; Moore, J.; Munoz, F.; Talavera, G.; O'Connor, G.T.; O'Donnell, C.; Orr, G.; Randal, F.; Theodorou, A.A.; Reiman, E.; Roxas-Murray, M.; Stark, L.; Tepp, R.; Zhou, A.; Topper, S.; Trousdale, R.; Tsao, P.; Weidman, L.; Weiss, S.T.; Wellis, D.; Whittle, J.; Wilson, A.; Zuchner, S.; Zwick, M.E.

In: Patterns. (Patterns, 12 August 2022, 3(8))

Sharma, Y.; Channamsetty, V.; Cox, L.; Kruger, L.; Haga, S.B.

In: Public Health Genomics. (Public Health Genomics, 7 January 2022, 25(1-2):12-21)

Scholle, S.H.; Nguyen-Louie, T.T.; Blaz, J.W.; Bifulco, L.; Blankson, M.L.; Channamsetty, V.; Anderson, D.R.

In: Journal of Pain Research. (Journal of Pain Research, 2022, 15:2249-2261)

Mulrooney, M.; Smith, M.; Lewis, K.; Vuernick, E.; Anderson, D.; Channamsetty, V.; Giannotti, T.

In: Journal of the American Pharmacists Association. (Journal of the American Pharmacists Association, 1 January 2022, 62(1):270-280)

Bifulco, L.; Anderson, D.R.; Blankson, M.L.; Channamsetty, V.; Blaz, J.W.; Nguyen-Louie, T.T.; Scholle, S.H.

In: JAMA Network Open. (JAMA Network Open, 27 July 2021, 4(7):E2118495)

Ravipati G; Aronow WS; Ahn C; Sujata K; Saulle LN; Channamsetty V; Weiss MB

American Journal of Therapeutics (AM J THER), Sep2006; 13(5): 400-403. (4p)

Channamsetty V; Aronow WS; Sorberra C; Butt A; Cohen M

American Journal of Therapeutics (AM J THER), 2006 Nov-Dec; 13(6): 513-515. (3p)

Khalique, O.; Aronow, W.S.; Mazar, M.; Schair, B.; Shao, J.; Channamsetty, V.; Ahn, C.

In: American Journal of Cardiology. (American Journal of Cardiology, 1 August 2007, 100(3):415-416)

Ravipati, G.; Aronow, W.S.; Channamsetty, V.; Sekhri, V.; Ahn, C.

In: American Journal of Cardiology. (American Journal of Cardiology, 1 November 2006, 98(9):1170-1171)

American Journal of Geriatric Cardiology. Mar/Apr2006, Vol. 15 Issue 2, p125-136. 12p. 4 Charts, 1 Graph.

Singh, P; Siegel, D; Channamsetty, V; Yadav, N; Visvalingam, V; Greenberg, R; Bank, S

GASTROENTEROLOGY; APR 2000, 118 4, pA1488-pA1488, 1p. Supplement: 2

Singh, P; Channamsetty, V; Visvalingam, V; Yadav, N; Greenberg, R; Bank, S

GASTROENTEROLOGY; APR 2000, 118 4, pA971-pA971, 1p. Supplement: 2

Denny JC; From the Departments of Biomedical Informatics and Medicine, Vanderbilt University Medical Center, Nashville (J.C.D.); the National Center for Advancing Translational Sciences (J.L.R.) and the All of Us Research Program (G.J., E.D.), National Institutes of Health, Bethesda, MD; the Institute for Genomic Medicine and Department of Neurology, Columbia University Irving Medical Center, New York (D.B.G.); and the Broad Institute, Cambridge (A.P., J.W.S.), and the Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston (J.W.S.) - both in Massachusetts.; Rutter JL; From the Departments of Biomedical Informatics and Medicine, Vanderbilt University Medical Center, Nashville (J.C.D.); the National Center for Advancing Translational Sciences (J.L.R.) and the All of Us Research Program (G.J., E.D.), National Institutes of Health, Bethesda, MD; the Institute for Genomic Medicine and Department of Neurology, Columbia University Irving Medical Center, New York (D.B.G.); and the Broad Institute, Cambridge (A.P., J.W.S.), and the Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston (J.W.S.) - both in Massachusetts.; Goldstein DB; From the Departments of Biomedical Informatics and Medicine, Vanderbilt University Medical Center, Nashville (J.C.D.); the National Center for Advancing Translational Sciences (J.L.R.) and the All of Us Research Program (G.J., E.D.), National Institutes of Health, Bethesda, MD; the Institute for Genomic Medicine and Department of Neurology, Columbia University Irving Medical Center, New York (D.B.G.); and the Broad Institute, Cambridge (A.P., J.W.S.), and the Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston (J.W.S.) - both in Massachusetts.; Philippakis A; From the Departments of Biomedical Informatics and Medicine, Vanderbilt University Medical Center, Nashville (J.C.D.); the National Center for Advancing Translational Sciences (J.L.R.) and the All of Us Research Program (G.J., E.D.), National Institutes of Health, Bethesda, MD; the Institute for Genomic Medicine and Department of Neurology, Columbia University Irving Medical Center, New York (D.B.G.); and the Broad Institute, Cambridge (A.P., J.W.S.), and the Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston (J.W.S.) - both in Massachusetts.; Smoller JW; From the Departments of Biomedical Informatics and Medicine, Vanderbilt University Medical Center, Nashville (J.C.D.); the National Center for Advancing Translational Sciences (J.L.R.) and the All of Us Research Program (G.J., E.D.), National Institutes of Health, Bethesda, MD; the Institute for Genomic Medicine and Department of Neurology, Columbia University Irving Medical Center, New York (D.B.G.); and the Broad Institute, Cambridge (A.P., J.W.S.), and the Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston (J.W.S.) - both in Massachusetts.; Jenkins G; From the Departments of Biomedical Informatics and Medicine, Vanderbilt University Medical Center, Nashville (J.C.D.); the National Center for Advancing Translational Sciences (J.L.R.) and the All of Us Research Program (G.J., E.D.), National Institutes of Health, Bethesda, MD; the Institute for Genomic Medicine and Department of Neurology, Columbia University Irving Medical Center, New York (D.B.G.); and the Broad Institute, Cambridge (A.P., J.W.S.), and the Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston (J.W.S.) - both in Massachusetts.; Dishman E; From the Departments of Biomedical Informatics and Medicine, Vanderbilt University Medical Center, Nashville (J.C.D.); the National Center for Advancing Translational Sciences (J.L.R.) and the All of Us Research Program (G.J., E.D.), National Institutes of Health, Bethesda, MD; the Institute for Genomic Medicine and Department of Neurology, Columbia University Irving Medical Center, New York (D.B.G.); and the Broad Institute, Cambridge (A.P., J.W.S.), and the Center for Genomic Medicine and Department of Psychiatry, Massachusetts General Hospital, Boston (J.W.S.) - both in Massachusetts.

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Bohula EA; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Wiviott SD; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; McGuire DK; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Inzucchi SE; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Kuder J; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Im K; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Fanola CL; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Qamar A; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Brown C; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Budaj A; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Garcia-Castillo A; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Gupta M; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Leiter LA; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Weissman NJ; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; White HD; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Patel T; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Francis B; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Miao W; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Perdomo C; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Dhadda S; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Bonaca MP; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Ruff CT; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Keech AC; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Smith SR; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Sabatine MS; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).; Scirica BM; From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE